Question 1

Does Rathbones Group own IBRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Rathbones Group holds 163,220 shares of IBRX (Immunitybio), worth $1.4M.

Question 2

How many shares of IBRX does Rathbones Group own?

Accepted Answer

As of its Q2 2026 13F, Rathbones Group holds 163,220 shares of IBRX (Immunitybio).

Question 3

What is Rathbones Group's IBRX position worth?

Accepted Answer

As of its Q2 2026 13F, Rathbones Group's IBRX position is worth $1.4M.

Question 4

Is Rathbones Group buying or selling IBRX?

Accepted Answer

In Q2 2026, Rathbones Group increased its IBRX position by 9,800 shares (+6.4%).

Question 5

When did Rathbones Group first buy IBRX?

Accepted Answer

Rathbones Group first reported IBRX in its Q3 2023 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	163,220	+6.4%	$1.4M	0.0%	$8.76	27
2026-Q1	Decreased	153,420	-5.0%	$1.2M	0.0%	$7.67	0
2025-Q4	Unchanged	161,420	0.0%	$319,611	0.0%	$1.98	0
2025-Q3	Increased	161,420	+37.5%	$397,093	0.0%	$2.46	31
2025-Q2	Increased	117,420	+21.5%	$309,988	0.0%	$2.64	28
2025-Q1	Increased	96,620	+8.1%	$290,826	0.0%	$3.01	25
2024-Q4	Increased	89,420	+21.8%	$228,915	0.0%	$2.56	28
2024-Q3	Unchanged	73,420	0.0%	$273,122	0.0%	$3.72	0